Sampre Nutritions Limited has entered into a significant manufacturing agreement with Reliance Consumer Products Limited (RCPL) on October 8, 2025. This agreement involves the production and supply of nutraceutical and food products, marking a major step forward for Sampre Nutritions in expanding its market footprint.
The agreement between Sampre Nutritions Limited and Reliance Consumer Products covers the manufacture, packing, and supply of various confectionery, nutraceutical, and food products, including hard-boiled confectionery, lollipops, and toffees.
These products will be produced in line with the specifications and quality standards of RCPL. This long-term partnership is expected to generate ₹12 crore to ₹15 crore in revenue annually over a three-year period.
Under the agreement, Sampre Nutritions will handle the production, packaging, and delivery of products as per RCPL’s requirements. Pricing will be determined by RCPL, and payments will be made as per invoices following delivery. The ownership and risk of the goods remain with Sampre Nutritions until they are accepted by RCPL.
The companies involved in this agreement, Sampre Nutritions and Reliance Consumer Products, are not related in terms of promoter groups or affiliates. Thus, the transaction does not fall under the category of related-party transactions, ensuring compliance with the arm's length principle.
Read More:Sampre Nutritions Approves ₹355 Crore FCCB Issue for Global Expansion; Share Price in Focus!
On October 17, 2025, Sampre Nutritions share price opened at ₹153.50 on BSE, above the previous close of ₹150.50. During the day, it surged to ₹153.50 and dipped to ₹153.45. The stock closed at ₹153.45 by the end of the day. The stock registered a moderate gain of 1.96%.
Over the past week, it has moved up by 8.14%, over the past month, it has moved up by 48.20%, and over the past 3 months, it has moved up by 246.08%.
Sampre Nutrition's new agreement with Reliance Consumer Products is poised to significantly boost its revenue stream. With an expected ₹12 crore to ₹15 crore in annual business over the next three years, this deal positions Sampre Nutritions for a stronger presence in the growing nutraceutical and food product market.
Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in securities are subject to market risks. Read all related documents carefully before investing.
Published on: Oct 20, 2025, 11:26 AM IST
Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates